HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

Hepatitis C virus (HCV) infection is a silent killer that leads to rapid progression of liver
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …

Dr. Aronsohn has no relevant financial affiliations to disclose (updated November 12, 2019).
Dr. Bhattacharya has no relevant financial affiliations to disclose (updated November 13 …

Introduction The introduction of direct-acting antivirals (DAAs) has significantly transformed
the therapeutic landscape for chronic C hepatitis virus (HCV) infection. However, there is still …

Since molecules with direct-acting antiviral (DAA) became available, the landscape of the
treatment of hepatitis C virus (HCV) infection has completely changed. The new drugs are …

Discussion There are currently no clinical guidelines to support decision-making when
retreating patients failing SOF/VEL/VOX rescue therapy. Genotype 3 HCV, consistent with …

In den letzten Dekaden wurden erhebliche Fortschritte bei der (frühzeitigen) Diagnostik und
Therapie gastrointestinaler onkologischer Erkrankungen erzielt. Allerdings bleibt die …

Abstract Background and Objective Recent advances in hepatitis C virus (HCV) diagnostic
testing methods allow for a one-stop simplified 'test and cure'approach. The cost …

Background Treatment of hepatitis C virus (HCV) has been dramatically improved with the
introduction of direct-acting antiviral agents (DAAs). Universal access to pangenotypic DAAs …